Antares Pharma: Making Medicines Feel Better

Scientific Publications

Curtis JR, Xie F, Zhang J, Chen L, Yun H, Beukelman T  T, Ginsberg S, Schiff MH. “Patterns of Oral and Subcutaneous Methotrexate Use among Rheumatoid Arthritis Patients Enrolled in the U.S. Medicare Program. “ Poster presented at: The American College of Rheumatology, November 14-19, 2014: Boston, Ma. DOWNLOAD


Gunn JL, Panopolou A , Steuer A. “Efficacy and Tolerability of Subcutaneous Methotrexate for Inflammatory Arthritis: A Retrospective Observational Cohort Study. “ Poster was presented at: The American College of Rheumatology, November 14-19, 2014: Boston, Ma. DOWNLOAD


Schiff MH, Simon LS, Dave KJ, Jaffe J, Freundlich B. “Self-Administered Methotrexate Using a Medi-Jet Auto-Injector Improves Bioavailability Compared with Oral Methotrexate in Adults with Rheumatoid Arthritis. “ Poster presented at Annual European Congress of Rheumatology, June, 12-15 2013: Madrid, Spain. DOWNLOAD


Hammond A, Batley M. “ Rheumatoid Arthritis Patients With Inadequate Response to Oral Methotrexate Maintain Satisfactory Disease Control and Durable Long-term Response When Switched to Subcutaneous Methotrexate Monotherapy. “ Poster was presented at The American College of Rheumatology, November 14-19, 2014; Boston, Ma. DOWNLOAD


Kivitiz A, McLain D, Hill J, Freundlich B, Jaffe J, “Nearly Pain-Free Self-Administration of Methotrexate Using an Investigational Auto-Injector: results of a Phase 2 Clinical Trial in Rheumatoid Arthritis Patients with Mild-to-Severe Functional Limitations.” Poster was presented at American College of Rheumatology, October 25-30, 2013: San Diego, CA. DOWNLOAD


Bernard Ng B. “Subcutaneous Methotrexate Is Associated With a Significantly Longer Duration of Methotrexate Monotherapy Compared With Oral Methotrexate in Patients With Rheumatoid Arthritis: Observations From the U.S. Veterans Affairs Database.”  Poster was presented at EULAR, June 11-14, 2014; Paris, France. DOWNLOAD


Ruffing V, RN. “Pain-Related Anxiety as a Barrier to Use of Methotrexate in Rheumatoid Arthritis: Comparing Conventional Vial, Needles, and Syringe with an Investigational Auto-Injector in Healthy Volunteers. “ Poster was presented at American College of Rheumatology, October 25-30, 2013: San Diego, CA. DOWNLOAD


Mueller R, Kempis J, Haile S, Schiff MH. “Effectiveness, Tolerability and Safety of Subcutaneous Methotrexate in Early Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data From the St. Gallen Cohort .”  Poster was presented at EULAR, June 11-14, 2014; Paris, France. DOWNLOAD


Schiff M, Jaffe J, Freundlich B, & Madsen P. (2014) "New autoinjector technology for the delivery of subcutaneous methotrexate in the
treatment of rheumatoid arthritis, Expert Review of Medical Devices", 11:5, 447-455, DOI: 10.1586/17434440.2014.929492 DOWNLOAD


Travanty M1, Calawa B2, Shalaby W3, Jozwiakowski M3, Haraldsen K4, "Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth" 1Product Development, Antares Pharma, Minneapolis, MN, USA; 2 Research Department, Design Science, Philadelphia, PA, USA; 3 Medical Affairs, AMAG Pharmaceuticals, Inc., Waltham, MA, USA; 4 Technical Operations & Project Management, AMAG Pharmaceuticals, Inc., Waltham, MA, USA. DOWNLOAD


Kaminetsky J, Jaffe J, Swerdloff S (2015) "Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study" Sexual Medicine 2015;3:269-279, DOI: 10.1002/sm2.80 DOWNLOAD